Literature DB >> 3871242

Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

J N Johannessen, C C Chiueh, R S Burns, S P Markey.   

Abstract

Primates and rodents show marked differences in sensitivity to the neurotoxic effects of MPTP. We and others have previously shown that the toxic effects of MPTP on nigrostriatal cells are dependent on the oxidative metabolism of MPTP to the quaternary species MPP+. We have therefore compared the distribution and metabolism of MPTP in the monkey and several rodent species. Three major differences have been identified: 1) the primate, but not the rodents, showed a persistently high concentration of MPTP metabolites in the caudate nucleus compared to other brain regions; 2) the rodent brains cleared MPTP and its metabolites much more rapidly than did the monkey, and; 3) the predominant metabolite retained by the monkey brain was MPP+, while MPP+ cannot be detected in rodent brains for more than a few hours after injection. The persistence of MPP+ in the primate brain may explain the heightened toxicity of MPTP in this species.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871242     DOI: 10.1016/0024-3205(85)90062-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  24 in total

Review 1.  Electrochemical Analysis of Neurotransmitters.

Authors:  Elizabeth S Bucher; R Mark Wightman
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2015-05-04       Impact factor: 10.745

2.  Selective decrease of immunoreactive tyrosine hydroxylase in nigrostriatum of adult male rats after N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.

Authors:  L L Vacca-Galloway; R Ikeda; S Y Coleman
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

3.  Susceptibility to a parkinsonian toxin varies during primate development.

Authors:  B A Morrow; R H Roth; D E Redmond; S Diano; J D Elsworth
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

4.  Transplacental effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on brain dopaminergic neurons in the mouse. An immunohistochemical study.

Authors:  S Furune; K Miura; K Watanabe; S Nagao; H Takahashi; M Sakai; M Spatz; I Nagatsu
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  L-dopa reverses the effects of MPP+ toxicity.

Authors:  G C Wagner; M F Jarvis; J G Rubin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.

Authors:  C J Sun; J N Johannessen; W Gessner; I Namura; W Singhaniyom; A Brossi; C C Chiueh
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 7.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 8.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

Review 9.  Clues to the mechanism underlying dopamine cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

10.  Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.

Authors:  M Del Zompo; M P Piccardi; S Ruiu; M Quartu; G L Gessa; A Vaccari
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.